IL6 and esophageal squamous cell carcinoma: The above results indicate that high levels of IL-6 can promote the malignant progression of ESCC by triggering the STAT3/Notch pathway, while GA can inhibit the malignant biological properties of ESCC by inhibiting the IL-6/STAT3/Notch pathway.